Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
3D Medicines Inc.’s Listing on the Stock Exchange of Hong Kong
Linmon Media Limited’s HK$420 Million Initial Public Offering
Harneys acted as Cayman Islands counsel to Linmon Media Limited on the matter. Clifford Chance provided Hong Kong and US legal advice and CM Law Firm...
JL MAG Rare-Earth Co., Ltd.’s Dual Primary Listing
Herbert Smith Freehills has advised JL MAG Rare-Earth Co., Ltd. on the deal. JL Mag produces high-performance NdFeB rare earth permanent magnets (REPMs), which are used...
Hangzhou SF Intra-city Industrial Co., Ld.’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills advised the joint sponsors involved in the IPO. Clifford Chance advised SF Intra-City Industrial Co. Ltd. SF Intra-city operates China’s largest third-party on-demand...
Shanghai HeartCare Medial Technology Corporation Limited’s HK$1.13 Billion Hong Kong Initial Public Offering
Herbert Smith Freehills has advised Shanghai HeartCare Medial Technology Corporation Limited (06609.HK) on its mainboard listing on the Stock Exchange of Hong Kong. O’Melveny & Myers...